These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35916710)

  • 21. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
    Yang H; Wei Q; Zhong X; Yang H; Li B
    Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mining hidden knowledge: embedding models of cause-effect relationships curated from the biomedical literature.
    Krämer A; Green J; Billaud JN; Pasare NA; Jones M; Tugendreich S
    Bioinform Adv; 2022; 2(1):vbac022. PubMed ID: 36699407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
    Wang J; Yang Z; Domeniconi C; Zhang X; Yu G
    Brief Bioinform; 2021 Mar; 22(2):1984-1999. PubMed ID: 32103253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Executable pathway analysis using ensemble discrete-state modeling for large-scale data.
    Palli R; Palshikar MG; Thakar J
    PLoS Comput Biol; 2019 Sep; 15(9):e1007317. PubMed ID: 31479446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fuse: multiple network alignment via data fusion.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Bioinformatics; 2016 Apr; 32(8):1195-203. PubMed ID: 26668003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix factorization-based data fusion for the prediction of lncRNA-disease associations.
    Fu G; Wang J; Domeniconi C; Yu G
    Bioinformatics; 2018 May; 34(9):1529-1537. PubMed ID: 29228285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
    Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
    Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GLIDE: combining local methods and diffusion state embeddings to predict missing interactions in biological networks.
    Devkota K; Murphy JM; Cowen LJ
    Bioinformatics; 2020 Jul; 36(Suppl_1):i464-i473. PubMed ID: 32657369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of driver genes based on gene mutational effects and network centrality.
    Tang YY; Wei PJ; Zhao JP; Xia J; Cao RF; Zheng CH
    BMC Bioinformatics; 2021 Sep; 22(Suppl 3):457. PubMed ID: 34560840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporating prior information into differential network analysis using non-paranormal graphical models.
    Zhang XF; Ou-Yang L; Yan H
    Bioinformatics; 2017 Aug; 33(16):2436-2445. PubMed ID: 28407042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-project and Multi-profile joint Non-negative Matrix Factorization for cancer omic datasets.
    Salazar DA; Pržulj N; Valencia CF
    Bioinformatics; 2021 Dec; 37(24):4801-4809. PubMed ID: 34375392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis.
    Ng S; Collisson EA; Sokolov A; Goldstein T; Gonzalez-Perez A; Lopez-Bigas N; Benz C; Haussler D; Stuart JM
    Bioinformatics; 2012 Sep; 28(18):i640-i646. PubMed ID: 22962493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-clustering phenome-genome for phenotype classification and disease gene discovery.
    Hwang T; Atluri G; Xie M; Dey S; Hong C; Kumar V; Kuang R
    Nucleic Acids Res; 2012 Oct; 40(19):e146. PubMed ID: 22735708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer driver drug interaction explorer.
    Hartung M; Anastasi E; Mamdouh ZM; Nogales C; Schmidt HHHW; Baumbach J; Zolotareva O; List M
    Nucleic Acids Res; 2022 Jul; 50(W1):W138-W144. PubMed ID: 35580047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease target prediction via matrix factorization.
    Marini S; Vitali F; Rampazzi S; Demartini A; Akutsu T
    Bioinformatics; 2019 Mar; 35(6):923-929. PubMed ID: 30169576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.
    Huang L; Brunell D; Stephan C; Mancuso J; Yu X; He B; Thompson TC; Zinner R; Kim J; Davies P; Wong STC
    Bioinformatics; 2019 Oct; 35(19):3709-3717. PubMed ID: 30768150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized identification of altered pathways in cancer using accumulated normal tissue data.
    Ahn T; Lee E; Huh N; Park T
    Bioinformatics; 2014 Sep; 30(17):i422-9. PubMed ID: 25161229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.